The role of GLP-1 receptor agonists in weight reduction and cardiovascular risk reduction - interview with Michael Nauck

from Medical Digest & Congress Report · host Medical Congress News

Prof. Michael A. Nauck has a long clinical experience with GLP-1 analogs, author of several scientific papers about their applications.  Video: https://congressreport.eu/scientific-contents/standalonecontent:role-glp-1-receptor-agonists-weight-reduction-and-cardiovascular-risk-reduction

Episode metadata supplied by the publisher feed · Published Nov 17, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

The role of GLP-1 receptor agonists in weight reduction and cardiovascular risk reduction - interview with Michael Nauck

0:00 10:22

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 10 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on November 17, 2021.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!